NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 15 11:10AM ET
5.01
Dollar change
-0.45
Percentage change
-8.24
%
Index- P/E- EPS (ttm)-0.62 Insider Own39.71% Shs Outstand24.25M Perf Week-40.29%
Market Cap154.27M Forward P/E- EPS next Y-0.17 Insider Trans0.00% Shs Float18.57M Perf Month-27.50%
Enterprise Value150.73M PEG- EPS next Q-0.04 Inst Own24.53% Short Float7.27% Perf Quarter763.46%
Income-9.79M P/S5142.34 EPS this Y66.67% Inst Trans7.91% Short Ratio1.26 Perf Half Y247.91%
Sales0.03M P/B46.63 EPS next Y32.00% ROA-324.29% Short Interest1.35M Perf YTD236.23%
Book/sh0.11 P/C41.36 EPS next 5Y- ROE-8041.70% 52W High14.11 -64.49% Perf Year1068.35%
Cash/sh0.12 P/FCF- EPS past 3/5Y57.17% 46.11% ROIC-361.25% 52W Low0.23 2078.22% Perf 3Y-29.37%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-55.07% - Gross Margin-403.85% Volatility47.96% 23.31% Perf 5Y-92.96%
Dividend TTM- EV/Sales5024.34 EPS Y/Y TTM80.60% Oper. Margin-47726.92% ATR (14)1.62 Perf 10Y-91.29%
Dividend Ex-Date- Quick Ratio2.37 Sales Y/Y TTM-3.70% Profit Margin-37653.85% RSI (14)41.54 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.37 EPS Q/Q62.27% SMA20-32.92% Beta1.69 Target Price10.00
Payout- Debt/Eq0.02 Sales Q/Q-100.00% SMA50-9.98% Rel Volume2.87 Prev Close5.46
Employees5 LT Debt/Eq0.00 EarningsMay 19 SMA200133.18% Avg Volume1.07M Price5.01
IPOOct 30, 2014 Option/ShortYes / Yes EPS/Sales Surpr.-180.00% - Trades Volume900,479 Change-8.24%
Jul-14-25 08:30AM
10:06AM
Jul-11-25 09:00AM
Jul-08-25 12:29PM
Jul-07-25 06:41PM
10:30AM Loading…
Jun-09-25 10:30AM
Jun-04-25 08:25AM
May-28-25 06:45PM
01:46PM
01:07PM
May-27-25 08:20AM
May-26-25 12:42PM
May-25-25 06:31PM
May-23-25 07:56PM
May-05-25 09:42AM
08:30AM Loading…
08:30AM
Apr-24-25 12:00PM
Mar-26-25 09:00AM
Jan-22-25 07:00AM
Nov-13-24 03:14PM
Oct-22-24 03:13PM
Aug-01-24 04:32AM
Jul-31-24 09:45AM
Jul-25-24 01:57PM
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.